NewEdge Wealth’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19M Sell
6,747
-2,196
-25% -$1.11M 0.04% 311
2025
Q4
$4.18M Buy
8,943
+1,673
+23% +$777K 0.05% 272
2025
Q3
$3.44M Sell
7,270
-453
-6% -$176K 0.05% 282
2025
Q2
$2.88M Buy
7,723
+573
+8% +$206K 0.05% 305
2025
Q1
$2.47M Sell
7,150
-23
-0.3% -$7.4K 0.04% 309
2024
Q4
$2.15M Sell
7,173
-1,515
-17% -$529K 0.04% 339
2024
Q3
$3.53M Buy
8,688
+5,712
+192% +$2.09M 0.06% 260
2024
Q2
$956K Sell
2,976
-31
-1% -$10.1K 0.02% 426
2024
Q1
$929K Buy
+3,007
New +$919K 0.02% 440

Other funds holding HCA

NewEdge Wealth's HCA Position: Q1 2026 in Review

NewEdge Wealth reduced its HCA Healthcare (HCA) stake by 25% in Q1 2026, selling an estimated $1.11M and leaving 6,747 shares worth $3.19M. The position accounts for 0.04% of the portfolio, ranked #311.

NewEdge Wealth first reported a position in HCA in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.18M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • NewEdge Wealth held 6,747 shares of HCA Healthcare worth $3.19M as of Q1 2026.
  • NewEdge Wealth sold 2,196 HCA Healthcare shares in Q1 2026, an estimated $1.11M.
  • HCA Healthcare made up 0.04% of NewEdge Wealth's portfolio in Q1 2026, its #311 holding.
  • NewEdge Wealth first reported a position in HCA Healthcare in Q1 2024 and has held it in 9 quarters since.
  • NewEdge Wealth's HCA Healthcare position peaked at $4.18M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.